Philip B. Gorelick

49.1k total citations · 10 hit papers
305 papers, 18.8k citations indexed

About

Philip B. Gorelick is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Philip B. Gorelick has authored 305 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Epidemiology, 94 papers in Pulmonary and Respiratory Medicine and 93 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Philip B. Gorelick's work include Acute Ischemic Stroke Management (138 papers), Cerebrovascular and Carotid Artery Diseases (88 papers) and Dementia and Cognitive Impairment Research (46 papers). Philip B. Gorelick is often cited by papers focused on Acute Ischemic Stroke Management (138 papers), Cerebrovascular and Carotid Artery Diseases (88 papers) and Dementia and Cognitive Impairment Research (46 papers). Philip B. Gorelick collaborates with scholars based in United States, United Kingdom and Canada. Philip B. Gorelick's co-authors include Ralph L. Sacco, Larry B. Goldstein, Robert J. Adams, Mark J. Alberts, Margaret Kelly‐Hayes, George Howard, David L. Nyenhuis, Philip A. Wolf, Hee‐Joon Bae and Dilip K. Pandey and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Philip B. Gorelick

294 papers receiving 18.0k citations

Hit Papers

Guidelines for Prevention of Stroke in Patients With Isch... 2001 2026 2009 2017 2006 2006 2003 2001 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
    2006 1.4k citations Ralph L. Sacco, Robert J. Adams et al. Stroke profile →
  2. Primary Prevention of Ischemic Stroke
    2006 1.0k citations Larry B. Goldstein, Robert J. Adams et al. Stroke profile →
  3. Vascular cognitive impairment
    2003 857 citations Philip B. Gorelick et al. profile →
  4. Primary Prevention of Ischemic Stroke
    2001 678 citations Larry B. Goldstein, Robert J. Adams et al. Stroke profile →
  5. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    2018 578 citations William B. White, Kenneth G. Saag et al. New England Journal of Medicine profile →
  6. Large Artery Intracranial Occlusive Disease
    2008 520 citations Philip B. Gorelick, Hee‐Joon Bae et al. Stroke profile →
  7. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
    2018 515 citations Philip B. Gorelick, George Howard et al. profile →
  8. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
    2016 487 citations Kristine Yaffe, Philip B. Gorelick et al. Hypertension profile →
  9. Vascular Cognitive Impairment
    2014 438 citations Philip B. Gorelick et al. profile →
  10. Racial-Ethnic Disparities in Stroke Care: The American Experience
    2011 368 citations Mitchell S.V. Elkind, Philip B. Gorelick et al. Stroke profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip B. Gorelick United States 65 7.0k 5.7k 5.5k 3.2k 2.8k 305 18.8k
Steven J. Kittner United States 59 5.6k 0.8× 5.6k 1.0× 4.5k 0.8× 2.3k 0.7× 2.2k 0.8× 139 15.1k
Mark J. Alberts United States 62 9.3k 1.3× 6.1k 1.1× 5.7k 1.0× 4.7k 1.5× 1.7k 0.6× 222 21.9k
Philip M. Bath United Kingdom 70 7.8k 1.1× 4.5k 0.8× 3.9k 0.7× 3.9k 1.2× 973 0.3× 457 18.1k
Bo Norrving Sweden 69 8.8k 1.3× 4.7k 0.8× 3.3k 0.6× 3.6k 1.1× 2.0k 0.7× 321 21.1k
Tatjana Rundek United States 75 4.6k 0.7× 7.2k 1.3× 4.8k 0.9× 1.7k 0.6× 1.4k 0.5× 511 18.8k
Carlos S. Kase United States 71 12.2k 1.8× 5.3k 0.9× 5.8k 1.1× 8.6k 2.7× 2.3k 0.8× 220 23.4k
Virginia J. Howard United States 73 8.2k 1.2× 10.2k 1.8× 6.6k 1.2× 3.4k 1.1× 1.8k 0.6× 455 26.4k
Ralph L. Sacco United States 74 4.9k 0.7× 5.1k 0.9× 3.7k 0.7× 2.0k 0.6× 1.4k 0.5× 193 16.4k
Robert J. Adams United States 61 7.5k 1.1× 4.4k 0.8× 4.7k 0.9× 3.0k 1.0× 975 0.3× 266 19.7k
Cheryl Bushnell United States 52 5.6k 0.8× 3.9k 0.7× 2.9k 0.5× 3.1k 1.0× 2.1k 0.7× 186 14.2k

Countries citing papers authored by Philip B. Gorelick

Since Specialization
Citations

This map shows the geographic impact of Philip B. Gorelick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip B. Gorelick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip B. Gorelick more than expected).

Fields of papers citing papers by Philip B. Gorelick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip B. Gorelick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip B. Gorelick. The network helps show where Philip B. Gorelick may publish in the future.

Co-authorship network of co-authors of Philip B. Gorelick

This figure shows the co-authorship network connecting the top 25 collaborators of Philip B. Gorelick. A scholar is included among the top collaborators of Philip B. Gorelick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip B. Gorelick. Philip B. Gorelick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gorelick, Philip B., et al.. (2025). Periprocedural Brain Health. Neurology. 105(12). e214427–e214427.
2.
Kim, Hyunsoo, Joon‐Tae Kim, Beom Joon Kim, et al.. (2025). Tenecteplase in Acute Ischemic Stroke: A Scientific Statement From the Korean Stroke Society. Journal of Clinical Neurology. 21(5). 384–384.
3.
Gorelick, Philip B. & Anders Wallin. (2025). Editorial for cerebral circulation cognition & behavior special issue on brain health. PubMed. 9. 100400–100400. 1 indexed citations
4.
Jeong, Han‐Yeong, Jong‐Moo Park, Hong‐Kyun Park, et al.. (2025). Characteristics of High‐Performance Low‐Volume Hospitals in Acute Stroke Care. Journal of the American Heart Association. 14(8). e038348–e038348.
5.
Maas, Matthew B., Simin Mahinrad, Sanaz Sedaghat, et al.. (2024). Effects and Thresholds of Young to Midlife Vascular Risks on Brain Health. Hypertension. 81(9). 1935–1944.
6.
Antonio‐Santos, Aileen A., et al.. (2024). Diversity, Equity, and Inclusion Lessons From Developing Stroke Education Programs for West Michigan Asian Communities. Stroke. 55(3). 757–761. 3 indexed citations
7.
Gorelick, Philip B., Atticus H. Hainsworth, & Anders Wallin. (2024). Introduction to the special issue on brain health. SHILAP Revista de lepidopterología. 6. 100208–100208.
8.
Mahinrad, Simin, Farzaneh A. Sorond, & Philip B. Gorelick. (2022). The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention. Clinics in Geriatric Medicine. 39(1). 123–134. 8 indexed citations
9.
Sorond, Farzaneh A. & Philip B. Gorelick. (2022). Brain Reserve, Resilience, and Cognitive Stimulation Across the Lifespan. Clinics in Geriatric Medicine. 39(1). 151–160. 7 indexed citations
10.
Kim, Jun Yup, Jihoon Kang, Beom Joon Kim, et al.. (2022). Annual Case Volume and One-Year Mortality for Endovascular Treatment in Acute Ischemic Stroke. Journal of Korean Medical Science. 37(36). e270–e270. 4 indexed citations
11.
Trifan, Gabriela, Philip B. Gorelick, & Fernando D. Testai. (2021). Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Circulation. 143(25). 2441–2453. 15 indexed citations
12.
Amin‐Hanjani, Sepideh, Alfred P. See, Xinjian Du, et al.. (2020). Natural History of Hemodynamics in Vertebrobasilar Disease. Stroke. 51(11). 3295–3301. 12 indexed citations
13.
Kang, Jihoon, Seong-Eun Kim, Hong‐Kyun Park, et al.. (2020). Routing to Endovascular Treatment of Ischemic Stroke in Korea: Recognition of Need for Process Improvement. Journal of Korean Medical Science. 35(41). e347–e347. 13 indexed citations
14.
Koehler, Tracy J., et al.. (2019). Stroke knowledge among middle and high school students. Journal of International Medical Research. 47(9). 4230–4241. 11 indexed citations
15.
White, William B., Kenneth G. Saag, Michael A. Becker, et al.. (2018). Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. New England Journal of Medicine. 378(13). 1200–1210. 578 indexed citations breakdown →
16.
Amin‐Hanjani, Sepideh, Tanya N. Turan, Xinjian Du, et al.. (2016). Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study. Journal of Stroke and Cerebrovascular Diseases. 26(2). 403–410. 28 indexed citations
17.
Gorelick, Philip B., Muhammad U. Farooq, & Jiangyong Min. (2014). Population-based approaches for reducing stroke risk. Expert Review of Cardiovascular Therapy. 13(1). 49–56. 3 indexed citations
18.
Zoppo, Gregory J. del, Philip B. Gorelick, & Wolfgang G. Eisert. (2010). Innate inflammation and stroke. 1 indexed citations
19.
Goldstein, Larry B., Robert J. Adams, Mark J. Alberts, et al.. (2006). Primary Prevention of Ischemic Stroke. Stroke. 37(6). 1583–1633. 1002 indexed citations breakdown →
20.
Gorelick, Philip B.. (1996). Atlas of cerebrovascular disease. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven J. Kittner Breakdown of academic impact, for papers by Mark J. Alberts Breakdown of academic impact, for papers by Philip M. Bath Breakdown of academic impact, for papers by Bo Norrving Breakdown of academic impact, for papers by Tatjana Rundek Breakdown of academic impact, for papers by Carlos S. Kase Breakdown of academic impact, for papers by Virginia J. Howard Breakdown of academic impact, for papers by Ralph L. Sacco Breakdown of academic impact, for papers by Robert J. Adams Breakdown of academic impact, for papers by Cheryl Bushnell
Rankless by CCL
2026